RESEARCH
Professor William Gutheil, Ph.D., established the School of Pharmacy's Drug Discovery and Metabolomics facility.
RESEARCH SPOTLIGHT: Drug Discovery and Metabolomics Facility
The School of Pharmacy’s Drug Discovery and Metabolomics LC-MS/MS shared instrumentation resource facility was established by Professor William Gutheil, Ph.D.
The facility uses liquid chromatography and mass spectrometry to distinguish small molecules, including complex mixtures of metabolic products. The facility assists with groundbreaking research into novel antibiotics and helps identify molecules that may be biomarkers for the diagnosis of disease and its progression. The use of this advanced instrumentation, and the computational methods surrounding the data analysis it requires, saves enormous time compared to methods used even a decade ago.
Part of the School of Pharmacy and Gutheil’s mission is to train student scientists to use the Drug Discovery and Metabolomics facility and teach them how to design experiments and methodologies. Currently, two students work to support the facility and, each year, many more are trained to run their own experiments with the instrumentation.
Because of Gutheil’s training, these students can go into industry or academia as the next generation of experienced researchers, working to develop new methods, new drugs and, in some cases, new instruments.
Gutheil is a renowned expert in his field of work and is involved with the American Chemical Society Kansas City Section. There, he helps link together many of the regional assets in chemistry. Gutheil earned his Ph.D. at the University of Southern California, and completed two postdocs at Harvard Medical School and Tufts University in Boston.
Drug Discovery and Metabolomics machines
Faculty awarded grant to enhance health-care communication
Faculty members Sarah Cox, Pharm.D., Carly Steuber, Pharm.D., and Mark Patterson, Ph.D., have been selected as recipients of an Entrepreneurship Innovation Grant for their proposal, “Designing a Health IT Prototype to Improve Clinician Communication Across Care Settings.”
The trio aims to progress health-care communication by testing health information technology (IT) solutions to find a method that can deliver seamless communication between health-care providers across various care facilities in Missouri that do not share an electronic health record. The Entrepreneurship Innovation Grant is funded by a larger grant given to UMKC by the Kauffman Foundation.
In a separate but complementary research project, Patterson used qualitative research to evaluate medication discrepancies that happen during transitions of care between hospitals and long-term care facilities. As a result of the six-year study, Patterson and his colleagues found data silos that were impeding the exchange of critical information between community pharmacies, hospitals and long-term care facilities. Patterson is now expanding his research to focus on the use of electronic health records in nursing homes. He uses health IT evaluative frameworks in his effort to complete a qualitative analysis of the role of health IT during transitions of care.
Ongoing research initiatives
Researchers at the School of Pharmacy continue to discover innovative solutions to challenging health-care issues.
- Kun Cheng, Ph.D., a Curators' Distinguished Professor, will conduct research from a grant recently funded by the National Cancer Institute. The study, “Normalizing PDAC Stroma with PCBP2 siRNA Nanoparticles to Improve the Antitumor Activity of Chemotherapy and Immunotherapy,” is part of a number of groundbreaking advances Cheng has led throughout his tenure with the school.
- Jerry Wyckoff, Ph.D., was recently awarded an Entrepreneurship Innovative Grant for his proposal titled “Creating a Pipeline for Pharmacy Business Entrepreneurship.” The intent of the proposal is to increase awareness of our Pharm.D./MBA program and expand opportunities for students in the program to engage with businesses while pursuing this combined degree. Wyckoff will work with students, faculty and staff at all three campus locations.
BY THE NUMBERS
Research Activity
NUMBER OF RESEARCH PROPOSALS AWARDED IN 2023
Division of Pharmacology and Pharmaceutical Sciences
Division of Pharmacy Practice and Administration
2023 GRANTS AND CONTRACTS
Division of Pharmacology and Pharmaceutical Sciences
Division of Pharmacy Practice and Administration
Publication of Original Research
NUMBER OF MANUSCRIPTS PUBLISHED IN 2023
Division of Pharmacology and Pharmaceutical Sciences
Division of Pharmacy Practice and Administration
AREAS OF EMPHASIS
Drug Discover/ Drug Delivery
Clinical Studies-Outcomes